Enterprise Value to EBITDA Multiple ratio Analysis of Teva Pharma Industries Ltd. - Deep Dive


Latest FY EV to EBITDA
Period Ending - Dec-23

82.70


Very Poor EV to EBITDA
Period Ending - Dec-22
-22.26

Very Poor EV to EBITDA
Growth
471.57 %
Trailing Twelve Months EV to EBITDA
Period Ending - Dec-23

12.62


Indecisive EV to EBITDA
EV to EBITDA Analysis of Teva Pharma Industries Ltd.
Enterprise Value to EBITDA of Teva Pharma Industries Ltd. with value of 82.70 implies that the company is overvalued.
EV to EBITDA Ratio of TEVA rose handsomely by 471.57 % this year.
EV to EBITDA Ratio with value of 82.70 was highest in Year Dec-23 in last Five Years.
EV to EBITDA Ratio with value of -25.97 was lowest in Year Dec-20 in last Five Years.
Latest EV to EBITDA Ratio with value of 82.70 is Greater than Average EV to EBITDA of 16.28 in last five years.
Other EV to EBITDA Related Info of TEVA that may interest you.
Teva Pharma Industries Ltd. Overview
CodePricePrevious PricePrice ChangeSector
TEVA17.1617.4 1.38 % Drug Manufacturers-Specialty & Generic
Fundamental AnalysisTechnical Analysis
Defination of Enterprise Value to EBITDA Multiple
Enterprise Value-to-EBITDA Ratio is used to compare a company's Enterprise Value to its EBITDA (Earnings before Interest, Taxes, Depreciation, and Amortization). It is useful to determine the value of a company, whether it is undervalued or overvalued.    more ..
Enterprise Value to EBITDA Multiple Formula
EV to EBITDA Related Ratios
EBITDAMarginEVToRevenuePriceToEarningRatio
Tsr Value Index
Low Value Stock
FY - Historical Enterprise Value to EBITDA Multiple of Teva Pharma Industries Ltd.
PeriodDec-23Dec-22Dec-21Dec-20Dec-19Dec-18Dec-17
EV to EBITDA82.70-22.2614.00-25.9732.92107.08-3.22
Change471.57 %-259.03 %153.90 %-178.87 %-69.26 %3427.85 %-118.31 %
You are view first 7 Records. Log in to view all 38 in Premium view
FY Chart of Enterprise Value to EBITDA Multiple of Teva Pharma Industries Ltd.


Note : All Data Generated at the End of Trading Hours (EOD Data)